Cencora, Inc. (COR)

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Symbol
COR
Exchange
NYSE
Sector
Healthcare
Industry
Medical Distribution
Market cap
$58.97B
52 week range
244.82 - 377.54

Valuation

Share price
$309.05 (close of 2026-10-02)
P/E (TTM)
22.86x
Price to book
18.21x
Price to free cash flow
14.53x
Enterprise value
$67.88B
Book value per share
$16.97

Price performance

PeriodChange
1 day-0.24%
5 days+0.69%
1 month-8.12%
3 months+4.23%
6 months-4.85%
Year to date-8.50%
1 year+0.16%
3 years+72.58%
5 years+157.95%
10 years+282.58%
All time+10376.27%

Members of Congress who disclosed COR trades

Jared Moskowitz · Alan Armstrong · Greg Landsman · Jefferson Shreve

Super investors holding COR

Ken Griffin (Citadel) · Ray Dalio (Bridgewater Associates)

Profitability and growth

Return on equity
88.96%
Return on invested capital
38.36%
Return on assets
2.03%
Return on capital employed
14.00%
Gross margin
3.57%
Net margin
0.48%
EBITDA margin
1.15%
Revenue growth
9.31%
Net income growth
2.99%
Free cash flow growth
6.99%

Cash flow and balance sheet

Free cash flow yield (TTM)
6.88%
Current ratio
0.93x
Net debt to EBITDA
1.72x

Latest reported year

Period end
2025-09-30
Fiscal year
2025
Revenue
$321.33B
Cost of revenue
$309.85B
Gross profit
$11.48B
EBITDA
$3.68B
Net income
$1.55B
Earnings per share
$8.02
Shares outstanding
193.82M

Income statement by year

Period endRevenueGross profitNet incomeEPS
2025-09-30$321.33B$11.48B$1.55B$8.02
2024-09-30$293.96B$9.91B$1.51B$7.60
2023-09-30$262.17B$8.96B$1.75B$8.62
2022-09-30$238.59B$8.30B$1.70B$8.15
2021-09-30$213.99B$6.94B$1.54B$7.48
2020-09-30$189.89B$5.19B-$3.41B$-16.65
2019-09-30$179.59B$5.14B$855.37M$4.07
2018-09-30$167.94B$4.61B$1.66B$7.61
2017-09-30$153.14B$4.55B$364.48M$1.67
2016-09-30$146.85B$4.27B$1.43B$6.73

Margins and returns by year

Period endGross marginNet marginReturn on equityReturn on capital
2025-09-303.57%0.48%88.96%38.36%
2024-09-303.37%0.51%191.82%82.78%
2023-09-303.42%0.67%261.94%66.83%
2022-09-303.48%0.71%2383.54%77.53%
2021-09-303.24%0.72%263.50%28.70%
2020-09-302.73%-1.80%405.98%-
2019-09-302.86%0.48%28.58%22.94%
2018-09-302.75%0.99%54.37%29.66%
2017-09-302.97%0.24%17.66%17.26%
2016-09-302.91%0.97%67.06%42.69%

Cash and debt by year

Period endCashDebt
2025-09-30$4.36B$7.54B
2024-09-30$3.13B$3.81B
2023-09-30$2.59B$4.15B
2022-09-30$3.39B$4.63B
2021-09-30$2.55B$6.38B
2020-09-30$4.60B$3.62B
2019-09-30$3.37B$4.03B
2018-09-30$2.49B$4.16B
2017-09-30$2.44B$3.43B
2016-09-30$2.74B$3.58B

Free cash flow by year

Period endFree cash flowStock-based compensation
2025-09-30$3.21B$147.96M
2024-09-30$3.00B$148.00M
2023-09-30$3.45B$124.62M
2022-09-30$2.21B$93.40M
2021-09-30$2.23B$99.59M
2020-09-30$1.84B$74.41M
2019-09-30$2.03B$58.87M
2018-09-30$1.07B$62.32M
2017-09-30$1.04B$62.21M
2016-09-30$2.71B$64.99M

Dividend history

Most recent payment
2026-08-14
Paid in the last twelve months
$2.40
Payment dateDividend per share
2026-08-14$0.60
2026-05-15$0.60
2026-02-13$0.60
2025-11-14$0.60
2025-08-15$0.55
2025-05-16$0.55
2025-02-14$0.55
2024-11-15$0.55

Investor relations

Next earnings report

Next confirmed report
2026-11-04
Consensus EPS estimate
$4.54

Past earnings dates

ReportedFiscal periodEPS estimate
2026-08-05Jun/2026$4.37
2026-05-06Mar/2026$4.80
2026-02-04Dec/2025$4.07
2025-11-05Sep/2025$3.79
2025-08-06Jun/2025$3.78
2025-07-29--
2025-05-07Mar/2025$4.08
2025-04-29--

Filings and sources

Company website
cencora.com
SEC filings
10-K, 10-Q and 8-K on EDGAR
Earnings calendar
All upcoming reports

Similar companies

Cardinal Health Inc (CAH) · McKesson Corp (MCK) · Henry Schein Inc (HSIC) · Insulet Corp (PODD) · Intuitive Surgical Inc (ISRG) · Globus Medical Inc (GMED) · Becton Dickinson & Co (BDX) · Zimmer Biomet Holdings, Inc. (ZBH)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades